Sermorelin
Also known as: GHRH 1-29, growth hormone releasing factor 1-29
Literature on sermorelin, a GHRH(1-29) analog used in growth hormone deficiency diagnostics and research settings.
What does the research say about Sermorelin?
Sermorelin stimulates pituitary GH secretion in diagnostic and research protocols. Indexed papers cover pediatric GH deficiency testing and adult endocrine investigation designs.
Synapse surfaces peer-reviewed research and researcher networks for informational purposes only. This page does not provide medical advice, dosing guidance, or treatment recommendations.
Research feed: Sermorelin
11 indexed papers matched to curated MeSH concepts in the last 90 days.
Research Peptides for Sale: Quality Standards for BPC-157, TB-500, Sermorelin and Epitalon Procurement
Technical review outlines quality verification standards for research peptides, suggesting improved procurement processes.
Therapeutic potential of growth hormone-releasing hormone analogues in cardiovascular and cerebrovascular diseases: mechanisms and preclinical evidence
Narrative review highlights GHRH analogues improving cardiovascular outcomes and neuroprotection in animal models, suggesting promising therapies.
Placental hormones, IGF-1, and early-life growth: endocrine links between birth size and infant metabolic programming-a systematic review.
Systematic review links placental hormones and IGF-1 with growth and metabolic outcomes, suggesting new therapeutic strategies.
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review
Critical review examines peptide drugs' effects in sport, highlighting risks for recreational and professional athletes.
GHRH and insulin hypersecretion from a pancreatic neuroendocrine tumor in multiple endocrine neoplasia type 1
Case report reveals GHRH and insulin cosecretion in a rare pancreatic tumor, suggesting complex endocrine interactions.
Can long-acting growth hormone improve adherence in pediatric growth hormone deficiency?
Narrative review summarizes adherence to long-acting growth hormone in children with growth hormone deficiency, suggesting gaps in evidence.
Peptidomimetic Long-Acting Growth Hormone-Releasing Hormone Agonists Promote Tissue Perfusion in Hindlimb Ischemia
Hybrid GHRH analogs improve tissue perfusion in ischemic hindlimb, suggesting new therapeutic avenues for vascular diseases.
Effect of Adjunctive Ozone Application Protocols on Dentin-Derived Growth Factor Release: An In Vitro Study
In vitro study evaluates ozone's role in enhancing growth factor release in dentin conditioning, suggesting protocol-specific impacts.
Modified Acetate Salt Form of GHRH-Antagonist Shows Anti-Leukemic Activity in Acute Myeloid Leukemia
Demonstrates anti-leukemic effects of a GHRH antagonist in acute myeloid leukemia, suggesting new treatment possibilities.
Nutritional Status of Children with Short Stature Is Oppositely Associated with Growth Hormone Peak in Stimulation Tests and Insulin-Like Growth Factor-1 Concentration
Case-control study examines nutritional status's link to growth hormone and IGF-1 in children with short stature, highlighting implications for diagnosis.
Researchers studying Sermorelin
Researcher network data is loading or unavailable for this topic.
Follow Sermorelin literature with AI-enriched clinical evidence on Synapse.
Search Sermorelin on SynapsePowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers